SFI
PHAS

Susquehanna Fundamental Investments’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
2021
Q1 		$53K Sell
2020
Q4 		$161K Sell
2020
Q3 		$206K Buy